VANECK ETF TRUST - BIOTECH ETF (BBH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2015 to Q4 2025

Type / Class
Equity / BIOTECH ETF
Symbol
BBH
Price per share
$189.26
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
653,055
Total reported value
$108,210,357
% of total 13F portfolios
0%
Share change
-89,176
Value change
-$15,130,070
Number of holders
105
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 105 institutional investors reported holding 653,055 shares of VANECK ETF TRUST - BIOTECH ETF (BBH).

Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 6,212 $1,187,171 +$155,259 $189.26 7
2025 Q3 653,055 $108,210,357 -$15,130,070 $165.68 105
2025 Q2 749,239 $114,979,884 -$11,533,621 $153.28 97
2025 Q1 809,347 $127,031,960 -$19,998,778 $157.33 100
2024 Q4 939,819 $147,548,690 +$12,979,898 $156.97 112
2024 Q3 855,131 $151,458,793 +$1,765,538 $177.39 112
2024 Q2 845,042 $142,291,824 -$9,704,013 $168.41 112
2024 Q1 904,203 $150,401,896 -$6,729,554 $166.33 110
2023 Q4 631 $104,311 +$104,311 $165.31 1
2023 Q3 972,708 $151,482,619 -$16,199,908 $155.73 109
2023 Q2 1,095,196 $170,725,902 +$21,683,598 $156.05 109
2023 Q1 943,886 $153,156,854 +$5,721,262 $162.09 111
2022 Q4 912,959 $145,847,067 +$17,940,617 $159.74 115
2022 Q3 797,300 $112,261,123 -$2,831,736 $140.78 100
2022 Q2 842,093 $122,770,145 -$595,682 $145.79 103
2022 Q1 837,205 $135,745,149 -$10,666,080 $162.12 109
2021 Q4 901,318 $170,444,978 +$17,767,188 $189.33 121
2021 Q3 804,156 $162,568,999 +$3,133,050 $202.13 116
2021 Q2 782,987 $157,877,686 -$1,425,547 $201.65 111
2021 Q1 787,982 $135,614,489 +$9,133,312 $175.44 104
2020 Q4 723,453 $122,749,533 -$11,374,397 $169.68 109
2020 Q3 748,849 $121,342,730 -$2,310,326 $162.08 99
2020 Q2 729,327 $118,836,542 +$35,271,806 $162.93 99
2020 Q1 501,262 $64,160,173 +$7,720,993 $128.00 79
2019 Q4 443,302 $61,799,840 -$5,718,155 $139.42 82
2019 Q3 539,341 $63,660,209 -$2,591,987 $117.98 77
2019 Q2 513,805 $66,246,073 -$3,694,539 $128.94 77
2019 Q1 546,805 $70,239,968 -$1,855,633 $128.49 85
2018 Q4 607,324 $67,362,554 -$4,555,178 $110.71 82
2018 Q3 638,166 $86,765,170 +$11,187,655 $136.02 81
2018 Q2 564,036 $67,830,955 -$7,377,488 $120.00 83
2018 Q1 626,209 $75,362,789 -$101,041,630 $120.32 81
2017 Q4 1,438,161 $179,227,773 -$52,448,808 $124.60 80
2017 Q3 1,853,785 $248,652,790 +$13,013,060 $134.12 78
2017 Q2 1,752,839 $220,201,303 -$1,783,807 $125.63 80
2017 Q1 1,776,367 $211,457,097 +$24,970,528 $119.05 77
2016 Q4 1,552,746 $167,133,340 +$17,796,212 $107.57 82
2016 Q3 1,396,149 $160,835,204 +$67,436,793 $115.20 76
2016 Q2 789,553 $81,322,378 +$76,059,153 $102.35 73
2016 Q1 35,334 $3,662,000 +$3,487,001 $103.64 5
2015 Q4 1,691 $214,000 +$213,000 $105.10 2